Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
- PMID: 16198765
- DOI: 10.1016/S0140-6736(05)67339-4
Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review
Erratum in
- Lancet. 2006 Mar 25;367(9515):986
Abstract
Background: Influenza vaccination of elderly individuals is recommended worldwide. Our aim was to review the evidence of efficacy and effectiveness of influenza vaccines in individuals aged 65 years or older.
Methods: We searched five electronic databases to December, 2004, in any language, for randomised (n=5), cohort (n=49), and case-control (n=10) studies, assessing efficacy against influenza (reduction in laboratory-confirmed cases) or effectiveness against influenza-like illness (reduction in symptomatic cases). We expressed vaccine efficacy or effectiveness as a proportion, using the formula VE=1-relative risk (RR) or VE*=1-odds ratio (OR). We analysed the following outcomes: influenza, influenza-like illness, hospital admissions, complications, and deaths.
Findings: In homes for elderly individuals (with good vaccine match and high viral circulation) the effectiveness of vaccines against influenza-like illness was 23% (95% CI 6-36) and non-significant against influenza (RR 1.04, 0.43-2.51). Well matched vaccines prevented pneumonia (VE 46%, 30-58) and hospital admission (VE 45%, 16-64) for and deaths from influenza or pneumonia (VE 42%, 17-59), and reduced all-cause mortality (VE 60%, 23-79). In elderly individuals living in the community, vaccines were not significantly effective against influenza (RR 0.19, 0.02-2.01), influenza-like illness (RR 1.05, 0.58-1.89), or pneumonia (RR 0.88, 0.64-1.20). Well matched vaccines prevented hospital admission for influenza and pneumonia (VE 26%, 12-38) and all-cause mortality (VE 42%, 24-55). After adjustment for confounders, vaccine performance was improved for admissions to hospital for influenza or pneumonia (VE* 27%, 21-33), respiratory diseases (VE* 22%, 15-28), and cardiac disease (VE* 24%, 18-30), and for all-cause mortality (VE* 47%, 39-54).
Interpretation: In long-term care facilities, where vaccination is most effective against complications, the aims of the vaccination campaign are fulfilled, at least in part. However, according to reliable evidence the usefulness of vaccines in the community is modest.
Comment in
-
Resistance to anti-influenza agents.Lancet. 2005 Oct 1;366(9492):1139-40. doi: 10.1016/S0140-6736(05)67340-0. Epub 2005 Sep 22. Lancet. 2005. PMID: 16198748 Free PMC article. No abstract available.
-
Influenza vaccination in elderly people.Lancet. 2005 Dec 17;366(9503):2086. doi: 10.1016/S0140-6736(05)67884-1. Lancet. 2005. PMID: 16360785 No abstract available.
Similar articles
-
Vaccines for preventing influenza in the elderly.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004876. doi: 10.1002/14651858.CD004876.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876. doi: 10.1002/14651858.CD004876.pub3. PMID: 16856068 Updated. Review.
-
Vaccines for preventing influenza in the elderly.Cochrane Database Syst Rev. 2010 Feb 17;(2):CD004876. doi: 10.1002/14651858.CD004876.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2018 Feb 01;2:CD004876. doi: 10.1002/14651858.CD004876.pub4. PMID: 20166072 Updated. Review.
-
Influenza vaccination for healthcare workers who work with the elderly.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005187. doi: 10.1002/14651858.CD005187.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2010 Feb 17;(2):CD005187. doi: 10.1002/14651858.CD005187.pub3. PMID: 16856082 Updated. Review.
-
Effectiveness of influenza vaccination in institutionalized older adults: a systematic review.J Am Med Dir Assoc. 2014 Mar;15(3):226.e1-226.e6. doi: 10.1016/j.jamda.2013.10.008. Epub 2013 Dec 8. J Am Med Dir Assoc. 2014. PMID: 24321878 Review.
-
Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review.Lancet Infect Dis. 2006 May;6(5):273-9. doi: 10.1016/S1473-3099(06)70462-5. Lancet Infect Dis. 2006. PMID: 16631547 Review.
Cited by
-
Quantifying and Adjusting for Confounding From Health-Seeking Behavior and Health Care Access in Observational Research.Open Forum Infect Dis. 2024 Oct 23;11(10):ofae598. doi: 10.1093/ofid/ofae598. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39474443 Free PMC article.
-
Systemic dysregulation and molecular insights into poor influenza vaccine response in the aging population.Sci Adv. 2024 Sep 27;10(39):eadq7006. doi: 10.1126/sciadv.adq7006. Epub 2024 Sep 27. Sci Adv. 2024. PMID: 39331702 Free PMC article.
-
Excessive daytime sleepiness is associated with impaired antibody response to influenza vaccination in older male adults.Front Cell Infect Microbiol. 2023 Dec 12;13:1229035. doi: 10.3389/fcimb.2023.1229035. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38149010 Free PMC article.
-
Dynamics of T-cell Responses Following COVID-19 mRNA Vaccination and Breakthrough Infection in Older Adults.Pathog Immun. 2023 Nov 17;8(1):117-135. doi: 10.20411/pai.v8i1.613. eCollection 2023. Pathog Immun. 2023. PMID: 38035132 Free PMC article.
-
Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities.Hum Vaccin Immunother. 2023 Dec 15;19(3):2271304. doi: 10.1080/21645515.2023.2271304. Epub 2023 Nov 6. Hum Vaccin Immunother. 2023. PMID: 37929779 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
